Investigation of the visceral fat and adipocytokine by SGLT2 inhibitors in type 2 diabetes millitus
Not Applicable
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000022561
- Lead Sponsor
- Dokkyo medical university, Endocrinology and Metabolism
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.Type 1 diabetes, secondary diabetes 2.Severe ketosis, diabetic coma, or before coma 3.Severe infection, before and not long after surgery, or patients with severe trauma 4.Severe cerebrovascular dysfunction, heart disorder, renal dysfunction and liver dysfunction 5.Heart failure(NYHA classification 3-4), patients treated by diuretic 6.Patients who have repeated urinary tract infections 7.Alchole intake excessive 8.Women suspected of pregnancy or pregnant 9.Patients with a history of use SGLT2 inhibitors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method